<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00783510</url>
  </required_header>
  <id_info>
    <org_study_id>P10-262</org_study_id>
    <nct_id>NCT00783510</nct_id>
  </id_info>
  <brief_title>Juvenile Idiopathic Arthritis (JIA) Registry</brief_title>
  <acronym>STRIVE</acronym>
  <official_title>A Long-term, Multi-center, Longitudinal Post-marketing, Observational Study to Assess Long Term Safety and Effectiveness of HUMIRA® (Adalimumab) in Children With Moderately to Severely Active Polyarticular or Polyarticular-course Juvenile Idiopathic Arthritis (JIA) - STRIVE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AbbVie</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AbbVie</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a global registry, to evaluate the long-term safety of Humira® in patients with
      moderate to severe polyarticular Juvenile Idiopathic Arthritis (JIA), that are treated as
      recommended in the Humira® product label. Patients treated with MTX will be considered a
      reference group. Patients will be followed in both the Humira® and Methotrexate (MTX) arms
      for 10 years from the enrollment date into one of the treatment arms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This registry will assess the incidence and rate of Humira (monotherapy or combination
      therapy with MTX) or MTX observational and treatment-emergent SAEs, Adverse Events of Special
      Interest (AESI) and Pregnancy in patients diagnosed with moderately to severely active
      polyarticular or polyarticular-course JIA through Year 5. From Year 6 through Year 10 SAEs, a
      subset of AESI that includes congestive heart failure (CHF), malignancies, AEs at least
      possibly related to and/or leading to discontinuation of registry treatment and pregnancies
      will be collected. For JIA patients 2 to&lt; 4 years of age in countries with available local
      approval for this group of patients at the time of consent to the registry, emergent AESI,
      SAEs and pregnancy (at the age when a patient can become pregnant) will be collected for the
      full 10 years. The approved age range for HUMIRA in the U.S., European Union (EU) and in
      Australia is 4 years of age and older, and recent approval in EU for JIA patients 2 to &lt; 4
      years of age.

      Patients who discontinue from the registry before 10 years will be offered to participate in
      the direct to Health Care Provider follow-up process, as allowed by local regulations.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">July 11, 2008</start_date>
  <completion_date type="Anticipated">February 6, 2024</completion_date>
  <primary_completion_date type="Anticipated">February 6, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of Serious Adverse Events (SAEs)</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Collected as events occur during the registry and as part of prior clinical studies. Events are collected retrospectively for patients who dosed prior to enrollment in the registry and as part of the Health Care Provider (HCP) process.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Adverse Events (AEs) of Interest</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Collected as events occur during the registry and as part of prior clinical studies. Events are collected retrospectively for patients who dosed prior to enrollment in the registry and as part of the Health Care Provider (HCP) process.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pediatric American College of Rheumatology (PedACR) 50</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Effectiveness data will be analyzed as observed and will be summarized for All Treated Patient Population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric American College of Rheumatology (PedACR) 70</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Effectiveness data will be analyzed as observed and will be summarized for All Treated Patient Population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric American College of Rheumatology (PedACR) - 30</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Effectiveness data will be analyzed as observed and will be summarized for All the Treated Patient Population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Child Health Questionnaire (CHQ-PF50)</measure>
    <time_frame>Assessed in months 1,3, 6 and every 6 months through Year 5</time_frame>
    <description>The results will be summarized at each visit and will be used in exploratory analyses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pediatric American College of Rheumatology (PedACR) 90</measure>
    <time_frame>Up to 10 years</time_frame>
    <description>Effectiveness data will be analyzed as observed and will be summarized for All Treated Patient Population.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Juvenile arthritis disease activity score (JADAS)</measure>
    <time_frame>Assessed in months 1,3, 6 and every 6 months through Year 5</time_frame>
    <description>Effectiveness data will be analyzed as observed and will be summarized for All Treated Patient Population. Is the total scores of four activity scales (Physician's Global Assessment of patient's disease, Parents' Global Assessment of patient's overall well-being, Number of active joints and Normalized erythrocyte sedimentation rate (ESR) if collected and available.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical function of the Disability Index of Childhood Health Assessment Questionnaire (DIHAQ)</measure>
    <time_frame>Assessed in months 1,3, 6 and every 6 months through Year 5</time_frame>
    <description>Effectiveness of therapy through clinical assessment.</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">849</enrollment>
  <condition>Juvenile Idiopathic Arthritis</condition>
  <condition>JIA</condition>
  <arm_group>
    <arm_group_label>HUMIRA® Treatment Arm</arm_group_label>
    <description>For patients taking HUMIRA®</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Methotrexate Treatment Arm</arm_group_label>
    <description>For patients taking Methotrexate</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>adalimumab</intervention_name>
    <description>As prescribed by treating physician</description>
    <arm_group_label>HUMIRA® Treatment Arm</arm_group_label>
    <other_name>HUMIRA®</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methotrexate</intervention_name>
    <description>As prescribed by treating physician</description>
    <arm_group_label>Methotrexate Treatment Arm</arm_group_label>
    <other_name>MTX</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients who are diagnosed at any time with moderately to severely active polyarticular or
        polyarticular-course JIA, (defined as arthritis affecting greater than 5 joints at the time
        of diagnosis of polyarticular or polyarticular-course JIA), prescribed and treated in a
        routine clinical setting either with Humira® (adalimumab), or MTX. Approximately 800
        patients will be enrolled in the United States, EU countries, and Australia. Approximately
        40 to 45 physicians will be included based on participation in prior AbbVie Humira
        sponsored clinical JIA studies.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  For a patient enrolling into the HUMIRA® arm; a pediatric patient diagnosed at any
             time with moderately to severely active polyarticular or polyarticular-course JIA
             (defined as arthritis affecting &gt;= 5 joints at the time of diagnosis of polyarticular
             or polyarticular-course JIA) who has been prescribed HUMIRA® therapy according to the
             local approved HUMIRA® product labeling and meets one of the following criteria:

          -  Enrolled patients are 4 to 17 years of age as per approved HUMIRA® product label with
             the addition of JIA patients 2 to &lt; 4 years of age in countries with available local
             approval for this group of patients at the time of consent to the registry.

          -  Newly initiated (within 24 months of registry entry) on HUMIRA® therapy and has
             received continuous (no more than 70 consecutive days off drug) HUMIRA® therapy, and
             the physician can provide available source documentation of SAEs, AEs of Special
             Interest, and dosing information since initiation of therapy;

          -  Or is entering after participation (within 24 months of registry entry or, if longer,
             continuously treated at the same site) in an AbbVie Humira sponsored study, regardless
             of age or the number of joints with symptoms of JIA, and has received continuous (no
             more than 70 consecutive days off drug) HUMIRA® therapy and the physician can provide
             available source documentation of SAEs, AEs of Special Interest, and dosing
             information since initiation of therapy.

          -  For a patient enrolling into the MTX arm; a pediatric patient diagnosed at any time
             with moderately to severely active polyarticular or polyarticular-course JIA (defined
             as arthritis affecting &gt;= 5 joints at the time of diagnosis of polyarticular or
             polyarticular-course JIA) who is prescribed MTX therapy alone or in combination with
             other disease modifying anti-rheumatic drugs (DMARDs) according to the local product
             labeling (initiated treatment within 24 months of registry entry) and has received
             continuous therapy and the physician can available provide source documentation of
             SAEs, AEs of Special Interest, and dosing information since initiation of therapy.

          -  Patients who were treated in the MTX arm of this registry and prematurely discontinued
             from the MTX arm due to being a non-responder, or became intolerant of MTX treatment
             or are in need of combination treatment with HUMIRA® therapy may be eligible to enroll
             into the HUMIRA® treatment arm if all ongoing AEs/SAEs have been resolved, and they
             meet inclusion criteria and can enroll within the registry enrollment period. In case
             of ongoing AEs/SAEs at the time of the treatment arm switch, the AbbVie Designated
             Physician should be contacted to assess the eligibility of patient to roll into Humira
             treatment arm.

          -  Parent or guardian has voluntarily signed and dated an informed consent/patient
             authorization form, approved by an Institutional Review Board (IRB)/Independent Ethics
             Committee (IEC) if applicable according to local law, after the nature of the registry
             has been explained and the patient's parent or legal guardian has had the opportunity
             to ask questions. Pediatric patients will be included in all discussions as per
             applicable local regulations in order to obtain verbal or written assent.

        Exclusion Criteria:

          -  Patients should not be enrolled into the HUMIRA® or Methotrexate (MTX) arm if they
             cannot be prescribed and treated in accordance with the approved local HUMIRA® and/or
             with the local MTX product label.

          -  Patients should not be enrolled into the HUMIRA® or MTX arm if they require on-going
             treatment with Kineret® (anakinra), Orencia® (abatacept), Rituxan® (rituximab),
             Enbrel® (etanercept), and Remicade® (infliximab), or any other approved biologic
             agents or investigational agents.

          -  Patients should not be enrolled into the MTX arm if they have had prior treatment with
             any investigational agent or anti-rheumatic biologic therapy such as, but not limited
             to, Orencia® (abatacept), Enbrel® (etanercept), Remicade® (infliximab), Rituxan®
             (rituximab), or Actemra® (tocilizumab).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>AbbVie Inc.</last_name>
    <role>Study Director</role>
    <affiliation>AbbVie</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>AZ Arthritis and Rheum Researc /ID# 21023</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85032-9306</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catalina Pointe Clinical Res /ID# 40227</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85704</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arkansas Children's Hospital /ID# 23505</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Childrens Hospital LA /ID# 24386</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's National Medical Center /ID# 23506</name>
      <address>
        <city>Washington</city>
        <state>District of Columbia</state>
        <zip>20010</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arthritis Associates South FL /ID# 17001</name>
      <address>
        <city>Delray Beach</city>
        <state>Florida</state>
        <zip>33484</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago /ID# 20966</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Chicago /ID# 21981</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60637-1443</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Methodist Medical Group Rheum /ID# 46343</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61602</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Indiana University /ID# 11421</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Louisville /ID# 23507</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arthritis Care Spec. of MD /ID# 21961</name>
      <address>
        <city>Ellicott City</city>
        <state>Maryland</state>
        <zip>21042</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tufts Medical Center /ID# 21965</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Creighton Univ Med Ctr /ID# 11423</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68131</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Barnabas Ambulatory Care /ID# 21025</name>
      <address>
        <city>West Orange</city>
        <state>New Jersey</state>
        <zip>07052</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Shore University Hospital /ID# 21022</name>
      <address>
        <city>New Hyde Park</city>
        <state>New York</state>
        <zip>11040</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ Rochester Med Ctr /ID# 20967</name>
      <address>
        <city>Rochester</city>
        <state>New York</state>
        <zip>14642</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>New York Medical College /ID# 21964</name>
      <address>
        <city>Valhalla</city>
        <state>New York</state>
        <zip>10595</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Duke University Medical Center - Main /ID# 22904</name>
      <address>
        <city>Durham</city>
        <state>North Carolina</state>
        <zip>27705-3976</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Bone Spine Sports/Medctr One /ID# 21962</name>
      <address>
        <city>Bismarck</city>
        <state>North Dakota</state>
        <zip>58501</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Akron Childrens Hospital /ID# 22907</name>
      <address>
        <city>Akron</city>
        <state>Ohio</state>
        <zip>44308</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Cincinnati /ID# 14101</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45267-0585</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Nationwide Childrens Hospital /ID# 21963</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Legacy Emanuel Medical Center /ID# 14102</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97227</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Christopher's Hospital /ID# 24385</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19134</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Arthritis Associates, PLLC /ID# 44462</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Dr. Ramesh Gupta /ID# 45342</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38119</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Scott &amp; White Health Care /ID# 36762</name>
      <address>
        <city>Round Rock</city>
        <state>Texas</state>
        <zip>78665</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah /ID# 21041</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112-5500</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Speciality Center /ID# 11503</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seattle Children's Hospital /ID# 20968</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children's Hospital Wisconsin /ID# 40226</name>
      <address>
        <city>Milwaukee</city>
        <state>Wisconsin</state>
        <zip>53226</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Womens and Childrens Hospital /ID# 59182</name>
      <address>
        <city>Adelaide</city>
        <state>South Australia</state>
        <zip>5006</zip>
        <country>Australia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medizinische Universität Wien /ID# 26127</name>
      <address>
        <city>Vienna</city>
        <state>Wien</state>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landeskrankenhaus Bregenz /ID# 26128</name>
      <address>
        <city>Bregenz</city>
        <zip>6900</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>LKH-Univ. Klinikum Graz /ID# 26126</name>
      <address>
        <city>Graz</city>
        <zip>8036</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Landes-Frauen und Kinderklinik /ID# 39068</name>
      <address>
        <city>Linz</city>
        <zip>4020</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Revmatologicky ustav Praha /ID# 43344</name>
      <address>
        <city>Prague 2</city>
        <state>Praha 2</state>
        <zip>128 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni Nemocnice v Motole /ID# 37342</name>
      <address>
        <city>Prague 5</city>
        <state>Praha 5</state>
        <zip>150 06</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fakultni Nemocnice Brno /ID# 37343</name>
      <address>
        <city>Brno</city>
        <zip>625 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinika detskeho a dorosto lek /ID# 47401</name>
      <address>
        <city>Prague</city>
        <zip>121 00</zip>
        <country>Czechia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aarhus University Hospital /ID# 25445</name>
      <address>
        <city>Aarhus N</city>
        <state>Midtjylland</state>
        <zip>8200</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rigshospitalet, Finsen Centre /ID# 25444</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHRU Lille - Hôpital Claude Huriez /ID# 25449</name>
      <address>
        <city>Lille CEDEX</city>
        <state>Hauts-de-France</state>
        <zip>59045</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Bretonneau - CHU Tours /ID# 27126</name>
      <address>
        <city>Tours CEDEX 9</city>
        <state>Indre-et-Loire</state>
        <zip>37044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU NANCY - Hôpital Brabois Adultes /ID# 25452</name>
      <address>
        <city>Vandoeuvre les Nancy CEDEX</city>
        <state>Meurthe-et-Moselle</state>
        <zip>54511</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse /ID# 37347</name>
      <address>
        <city>Toulouse CEDEX 3</city>
        <state>Occitanie</state>
        <zip>31025</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Bordeaux-Hopital Pellegrin /ID# 25454</name>
      <address>
        <city>Bordeaux</city>
        <zip>33076</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Bicetre /ID# 25443</name>
      <address>
        <city>Le Kremlin Bicetre</city>
        <zip>94270</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Groupe Hospitalier Cochin /ID# 37345</name>
      <address>
        <city>Paris</city>
        <zip>75014</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospitalier Necker /ID# 25442</name>
      <address>
        <city>Paris</city>
        <zip>75015</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU de Rennes - Hospital Sud /ID# 27123</name>
      <address>
        <city>Rennes</city>
        <zip>35203</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Strasbourg Hautepierre Hos /ID# 25450</name>
      <address>
        <city>Strasbourg</city>
        <zip>67200</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité Universitätsmedizin Campus Mitte /ID# 41623</name>
      <address>
        <city>Berlin</city>
        <zip>10117</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Helios Klinikum Berlin Buch /ID# 37348</name>
      <address>
        <city>Berlin</city>
        <zip>13125</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Bremen Mitte gGmbH /ID# 45942</name>
      <address>
        <city>Bremen</city>
        <zip>28205</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Dortmund gGmbH /ID# 44003</name>
      <address>
        <city>Dortmund</city>
        <zip>44137</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center Rheumatology Child&amp;Adol /ID# 39069</name>
      <address>
        <city>Garmisch-partenkirchen</city>
        <zip>82467</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kinder- &amp; Jugendrheumatologie /ID# 39223</name>
      <address>
        <city>Hamburg</city>
        <zip>22081</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum St. Georg gGmbH /ID# 37349</name>
      <address>
        <city>Leipzig</city>
        <zip>04129</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asklepios Klinik St. Augustin /ID# 41622</name>
      <address>
        <city>Sankt Augustin</city>
        <zip>53757</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Tubingen /ID# 39070</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rheumazentrum Wedel /ID# 37350</name>
      <address>
        <city>Wedel</city>
        <zip>22880</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Children`s Hosp P. A. Kyriakou /ID# 25448</name>
      <address>
        <city>Athens</city>
        <zip>11527</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Genl Hosp Thessaloniki Hipp /ID# 25447</name>
      <address>
        <city>Thessaloniki</city>
        <zip>54642</zip>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Orszagos Reumatologiai es Fizi /ID# 95095</name>
      <address>
        <city>Budapest</city>
        <zip>1023</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Debreceni Egyetem Klinikai Koz /ID# 95863</name>
      <address>
        <city>Debrecen</city>
        <zip>4032</zip>
        <country>Hungary</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico /ID# 26124</name>
      <address>
        <city>Milan</city>
        <state>Lombardia</state>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera Univ. Meyer /ID# 26123</name>
      <address>
        <city>Florence</city>
        <state>Toscana</state>
        <zip>50139</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ. degli Studi di Brescia /ID# 39077</name>
      <address>
        <city>Brescia</city>
        <zip>25123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universita di Catania /ID# 39075</name>
      <address>
        <city>Catania</city>
        <zip>95123</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Univ degli Studi G D'Annunzio /ID# 37353</name>
      <address>
        <city>Chieti</city>
        <zip>66100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IRCCS Istituto G. Gaslini /ID# 26668</name>
      <address>
        <city>Genoa</city>
        <zip>16147</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Naples Federico /ID# 39072</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Naples Federico /ID# 39078</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Fondazione IRCCS Policlinico /ID# 39076</name>
      <address>
        <city>Pavia</city>
        <zip>27100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Osp. Pediatrico Bambino Gesu /ID# 39074</name>
      <address>
        <city>Rome</city>
        <zip>00146</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Medisch Centrum Utrecht /ID# 48842</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oslo Universitetssykehus, Radiumhospitalet /ID# 46402</name>
      <address>
        <city>Oslo</city>
        <zip>0310</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Garcia de Orta, E.P.E /ID# 37355</name>
      <address>
        <city>Almada</city>
        <state>Setubal</state>
        <zip>2805-267</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar Lisboa Norte, EPE /ID# 42682</name>
      <address>
        <city>Lisboa</city>
        <zip>1649-035</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro Hospitalar do Porto /ID# 39081</name>
      <address>
        <city>Porto</city>
        <zip>4099-001</zip>
        <country>Portugal</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centro de Reumatologia Pediatrico de Puerto Rico /Id# 61047</name>
      <address>
        <city>Bayamon</city>
        <zip>00959</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Puerto Rico Children Hospital /ID# 47742</name>
      <address>
        <city>Bayamon</city>
        <zip>00960</zip>
        <country>Puerto Rico</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Narodny ustav reumatickych chorob Piestany /ID# 38102</name>
      <address>
        <city>Pieštany</city>
        <zip>921 01</zip>
        <country>Slovakia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Univ Vall d'Hebron /ID# 37357</name>
      <address>
        <city>Barcelona</city>
        <zip>08035</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Sant Joan de Deu /ID# 37358</name>
      <address>
        <city>Esplugues de Llobregat</city>
        <zip>08950</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Severo Ochoa Hospital /ID# 41751</name>
      <address>
        <city>Leganes-madrid</city>
        <zip>28911</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hosp Infantil Univ Nino Jesus /ID# 37360</name>
      <address>
        <city>Madrid</city>
        <zip>28009</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Univ Ramon y Cajal /ID# 41624</name>
      <address>
        <city>Madrid</city>
        <zip>28034</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario La Fe /ID# 37359</name>
      <address>
        <city>Valencia</city>
        <zip>46026</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Silvia Children's Hosp /ID# 26125</name>
      <address>
        <city>Goteborg</city>
        <zip>416 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Czechia</country>
    <country>Denmark</country>
    <country>France</country>
    <country>Germany</country>
    <country>Greece</country>
    <country>Hungary</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Portugal</country>
    <country>Puerto Rico</country>
    <country>Slovakia</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>United States</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <verification_date>August 2019</verification_date>
  <study_first_submitted>October 28, 2008</study_first_submitted>
  <study_first_submitted_qc>October 30, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 31, 2008</study_first_posted>
  <last_update_submitted>August 19, 2019</last_update_submitted>
  <last_update_submitted_qc>August 19, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>JIA</keyword>
  <keyword>Juvenile Idiopathic Arthritis</keyword>
  <keyword>Juvenile Arthritis</keyword>
  <keyword>Polyarticular JIA</keyword>
  <keyword>Polyarticular-course JIA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Juvenile</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adalimumab</mesh_term>
    <mesh_term>Methotrexate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

